4//SEC Filing
Daniels Mark 4
Accession 0001214659-21-002457
CIK 0001581280other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:49 PM ET
Size
8.9 KB
Accession
0001214659-21-002457
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$23.33/sh+620$14,465→ 67,546 total - Sale
Common Stock
2021-02-24$134.31/sh−620$83,272→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-24−620→ 19,855 totalExercise: $23.33Exp: 2029-10-23→ Common Stock (620 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753840
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:49 PM ET
- Size
- 8.9 KB